TATAA Biocenter to distribute MethylDetect’s DNA methylation assays and co-develop methods courses

Uncategorized

Göteborg, Sweden, and Aalborg, Denmark 03-07-2019   TATAA Biocenter to distribute MethylDetect’s DNA methylation assays TATAA Biocenter inks distribution agreement with MethylDetect to provide their DNA methylation assays in Scandinavia, Czech and Slovak Republics. “As Scandinavia’s leading distributor of molecular analyses products, we are constantly expanding our offerings with novel solutions, new innovations and important…

Ampliqon A/S and Methyldetect ApS inked a collaboration agreement

Uncategorized

5thof February 2019 Aarhus-Odense, Denmark   MethylDetect ApS, an Aarhus based company established in 2017, to commercialize their proprietary methylation biomarker detection technology invented at Aarhus University. Compared to other available assays the technology is specific, sensitive, rapid, cost effective and run on standard PCR equipment.   Ampliqon A/S is a well-established biotech company located…

Our assay helps to identify cancer predisposition – Lynch Syndrome

News

MethylDetect’s assay targetting MLH1 gene is now a part of the NICE-mandated Lynch Syndrome pre-screen test. The results showing the performance of our MLH1 methylation testing assays, performed in collaboration with Sarah Cannon Molecular Diagnostics, https://sarahcannon-md.co.uk , were presented at the National Cancer Research Institute conference 2018. see: MLH1 Promoter Hypermethylation: Development and Preliminary Validation of a Methylation-Specific High…